PF21 Course Co-Directors:

Nathan Bahary, MD, PhD        Steven J. Hughes, MD
Randall E. Brand, MD              Aliye Uc, MD
Gregory A. Coté, MD, MS        David C. Whitcomb, MD, PhD

Course Faculty Disclosures

All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

The following relevant financial relationships were disclosed:
▪ Nathan Bahary, MD, PhD is a consultant with AstraZeneca, Exelixis, and Bristol Myers Squibb.
▪ Jodie Barkin, MD is a consultant with Abbvie Inc., Nestle Health Sciences Inc., HealthiVibe Inc., and Envara Health Inc.
▪ Randall Brand, MD receives grant/research support from Freenome and Immunovia.
▪ Gregory Cote, MD, MS receives grant/research support from Kangen Pharmaceuticals. He is also a consultant with the Olympus Corporation and is on the CE speakers’ bureau for Abbvie.
▪ Toren Finkel, MD, PhD is a stockholder with Generian Pharmaceuticals.
▪ A. Jay Freeman, MD, MSc receives grant/research support from the NIH, CFF, Vertex Pharmaceuticals, and Travere Therapeutics. He is also a consultant with Abbvie.
▪ Anna Gloyn, DPhil is a stockholder with Genentech and holds stock options with Roche.
▪ Vivek Kaul, MD is a consultant with Cook Medical, Steris Corp, Ambu, and Microtech.
▪ Peter Lee, MBChB is on an Abbvie advisory board.
▪ Michael Lotze, MD is a consultant with iRepoertoire and Checkmate. He is also the Chief Cell Therapy Officer for Nurix Therapeutics.
▪ Mark Lowe, MD, PhD is a consultant with the CF Foundation. He also receives royalties from UptoDate and Sigma-Millipore.
▪ Georgios Papachristou, MD, PhD receives grant/research support from the NIDDK, DOD, and Abbvie. He is also a consultant with Nestle.
▪ Michael Rickels, MD, MS is a consultant with Semma Therapeutics and the Sernova Corporation.
▪ Vijay P. Singh, MD, MBBS is a consultant with Lamassu Pharma, LLC.
▪ Vikesh Singh, MD, MSc receives grant/research support from Orgenesis and Theraly, and he is a consultant for Abbvie and Nestle Health Science. He is also an advisory board participant for Envara.
▪ Virginia Stallings, MD receives grant/research support from the NIH, HHS, CF Foundation, Vertex, Abbvie, and Chiesi. She is a consultant for Abbvie, Abbott, Envara Health, and Nestle Nutrition Sciences. She is also a stockholder with Danone and Envara Health.
▪ Eva Szigethy, MD, PhD receives grant/research support from PCORI and the NIH, and she is associated with APPI.
▪ David Whitcomb, MD, PhD receives grant/research support from the NIH, Dept. of Defense, and the Wayne Fussaro Pancreatic Cancer Research Fund. He is a consultant with Abbott, Ariel Precision Medicine, BioNTech, Nestle, Novartis, Regeneron, and Samsung. He is also a stockholder with Ariel Precision Medicine.

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Disclaimer Statement
The information presented at this CME program represents the views and opinions of the individual presenters and does not constitute the opinion of endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements.  However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.